|Bid||23.79 x 800|
|Ask||23.81 x 1100|
|Day's Range||23.74 - 24.16|
|52 Week Range||21.06 - 27.89|
|Beta (5Y Monthly)||1.35|
|PE Ratio (TTM)||7.35|
|Earnings Date||Feb 07, 2022 - Feb 11, 2022|
|Forward Dividend & Yield||0.52 (2.18%)|
|Ex-Dividend Date||Dec 09, 2021|
|1y Target Est||28.20|
Subscribe to Yahoo Finance Plus to view Fair Value for CNOLearn more
CNO Financial Group, Inc. (NYSE: CNO) has named Richard Shaffer senior vice president, small market sales and Worksite insurance operations. Shaffer reports to Michael Byers, president of CNO's Worksite Division. The appointment was effective December 6, 2021.
Elmsford, NY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive interim results from an independent, real world patient study of its UroShield at Southampton University Health Sciences. Brian Murphy, CEO of Nanovibronix, stated, “Interim results and observations from both the patient qualitative work and laborat
It looks like CNO Financial Group, Inc. ( NYSE:CNO ) is about to go ex-dividend in the next 4 days. The ex-dividend...